French Registry of CMR Late Gadolinium Enhancement in Myocarditis
ConditionMyocarditis Acute
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Acute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable personalized treatments and reduce mortality and major cardiovascular events.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Ability to provide informed non-opposition
AM diagnosis confirmed using CMR, fulfilling the modified Lake Louise diagnostic criteria
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov